NEOPRISM-CRC
Phase 2 Recruiting
88 enrolled
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Phase 1 Recruiting
50 enrolled
A Study of PHN-012 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
165 enrolled
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Phase 2 Recruiting
38 enrolled
PSI-Immune
Phase 2 Recruiting
880 enrolled
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Phase 3 Recruiting
700 enrolled
NIMA
Phase NA Recruiting
120 enrolled
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Phase 1 Recruiting
145 enrolled
Collection of Blood From Patients With Cancer
Recruiting
1,750 enrolled
Genomic Services Research Program
Recruiting
5,000 enrolled
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Phase 1 Recruiting
51 enrolled
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
Phase 1 Recruiting
22 enrolled
KANDLELIT-012
Phase 3 Recruiting
477 enrolled
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Recruiting
50 enrolled
Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
Phase NA Recruiting
70 enrolled
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Phase 3 Recruiting
800 enrolled
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Recruiting
750 enrolled
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Phase NA Recruiting
420 enrolled
TRIDENT-1
Phase 1/2 Recruiting
500 enrolled 5 FDA
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Phase NA Recruiting
400 enrolled
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Phase 1 Recruiting
188 enrolled
FORTE
Phase NA Recruiting
9,500 enrolled
CIRCULATE-US
Phase 2/3 Recruiting
1,912 enrolled
AZUR-4
Phase 2 Recruiting
120 enrolled
SURGE
Phase NA Recruiting
300 enrolled
ASAP
Recruiting
25,000 enrolled
LICOSARH
Recruiting
249 enrolled
MIMICC
Phase NA Recruiting
2,500 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Phase 1/2 Recruiting
47 enrolled
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Phase 1 Recruiting
48 enrolled
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
Phase 2/3 Recruiting
308 enrolled
SOLAR
Recruiting
3,375 enrolled